ESMO - The Christie Preceptorship on Lung Cancer 2025: Manchester

12 - 14 Mar 2025

Manchester, United Kingdom

ESMO-Preceptorship-Lung-Cancer-1000x1000

Slides and Webcasts from all ESMO Preceptorships are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Meeting programme Next/upcoming meetings

Learning objectives

To learn about the evidence-base for lung cancer screening and novel diagnostic modalities
To learn about the management of early-stage NSCLC and use of adjuvant treatments
To understand the role of multi-modality treatment in locally advanced NSCLC and limited stage SCLC
To learn about the management of patients with actionable driver mutations and novel targeted agents for advanced NSCLC
To understand the role of immune-checkpoint blockade for lung cancer and to learn about novel immunotherapies
To learn about treatment of NSCLC with oligometastatic disease
To learn about the systemic treatment of mesothelioma and SCLC
To learn about the role of supportive and palliative care for thoracic malignancies

Supported by BeiGene, Daiichi-Sankyo/AstraZeneca, Johnson & Johnson and Novocure.
Supporters have no influence over the content of ESMO courses.

Hide

There are 36 resources available